TORONTO--(BUSINESS WIRE)--ILAN ROSE has been named Vice President of Business Development and Project Management of BioPharma Services Inc. (BPSI) as of June 9, 2014. Previously, Ilan was with Alcmaeon Pharma Inc., where he was responsible for focusing on contract sales, as well as managing compliance audits.
Ilan brings to BioPharma Services Inc. an extensive knowledge of CRO and Phase I scientific matters combined with a proven track record of global sales in the field, gained through progressive positions throughout his career. He has held senior business development roles with CRO organizations such as Cirion Clinical Trial Services and Anapharm Inc., a Pharmanet Company.
Ilan graduated with a Bachelor of Science degree, majoring in Biology, from Concordia University in 1991; a Health and Social Services Management certificate from McGill University in 1994; and a Master of Business Administration from McGill University in 1997. He is fluently bilingual in French and English.
BPSI’s Chief Executive Officer, Renzo DiCarlo, stated: “We were very pleased with the executive search firm that we engaged, being TWC International Executive Search, and the extensive and sensitive process that we followed in partnership with the firm in order to create a just and deserving legacy to Lorelei's memory and to build upon the outstanding work that Lorelei had started during her tenure with our company.”
You can also reach Ilan Rose directly at (416) 747-8484, or by email at irose@biopharmaservices.ca.
About BioPharma Services Inc. BioPharma Services Inc. is a physician-owned, physician-run, FDA-inspected, UK MHRA-inspected, and Health Canada-inspected International Contract Research Organisation (CRO) which specializes in the conduct of Phase I/IIa clinical trials and bioanalysis for innovative pharmaceutical, biotech and medical device companies from US, Canada, Australia and Europe. The company currently has a modern 174-bed clinical facility and a co-located bioanalytical laboratory in Toronto, Canada. The company is privately held and is headquartered in Toronto, Canada.
